Lb Pharmaceuticals (LBRX) Prepaid Assets (2024 - 2026)

Lb Pharmaceuticals (LBRX) recorded quarterly Prepaid Assets of $1.4 million in Q1 2026, down 89.55% quarter-over-quarter from $13.2 million in Q4 2025.

Lb Pharmaceuticals (LBRX) Prepaid Assets (2024 - 2026) Analysis & Trends

Lb Pharmaceuticals' Prepaid Assets history runs 3 years deep, the most recent figure standing at $1.4 million for Q1 2026.

  • In Q1 2026, Prepaid Assets changed N/A year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (changed N/A YoY), while the FY2025 annual figure was $13.2 million, up 4814.13% from the prior year.
  • Prepaid Assets was $1.4 million for Q1 2026 at Lb Pharmaceuticals, down from $13.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $13.2 million in Q4 2025 to a low of $269000.0 in Q4 2024.
  • Historically, Prepaid Assets has averaged $4.2 million across 3 years, with a median of $1.7 million in 2025.
  • Biggest YoY gain for Prepaid Assets was 4814.13% in 2025; the steepest drop was 4814.13% in 2025.
  • A 3-year view of Prepaid Assets shows it stood at $269000.0 in 2024, then surged by 4814.13% to $13.2 million in 2025, then tumbled by 89.55% to $1.4 million in 2026.
  • The last three Prepaid Assets figures came in at $1.4 million (Q1 2026), $13.2 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Lb Pharmaceuticals 843.30 Mn 843.30 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 1.38 Mn
Dec 31, 2025 13.22 Mn
Sep 30, 2025 1.92 Mn
Dec 31, 2024 269,000.00